Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis

B. Njei, T. R. McCarty, B. E. Fortune, J. K. Lim

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry